Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.

Jacquelot, Nicolas; Pitt, Jonathan M; Enot, David P; Roberti, Maria Paula; Duong, Connie P M; Rusakiewicz, Sylvie; Eggermont, Alexander M; Zitvogel, Laurence

Jacquelot, Nicolas; Pitt, Jonathan M; Enot, David P; Roberti, Maria Paula; Duong, Connie P M; Rusakiewicz, Sylvie; Eggermont, Alexander M; Zitvogel, Laurence.

Afiliação

Jacquelot N; Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France.
Pitt JM; Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France.
Enot DP; Gustave Roussy, Université Paris-saclay, Metabolomics and Cell Biology Platforms, Villejuif, F-94805, France.
Roberti MP; Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France.
Duong CPM; Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France.
Rusakiewicz S; Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France.
Eggermont AM; Gustave Roussy, Université Paris-saclay, CIC Biothérapie IGR Curie CIC 1428, Villejuif, F-94805, France.
Zitvogel L; Gustave Roussy, Université Paris-saclay, Villejuif, F-94805, France.

Oncoimmunology ; 6(8): e1299303, 2017.

Article em En | MEDLINE | ID: mdl-28919986

Palavras-chave

Immune biomarkers; Immunotherapy; Melanoma; Predictive factors; Prognostic factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google